FDA Adverse Event Death Summary report: N

MAQUET - AXILLO-BIFEMORAL HEMOGARD KNITTED

MDR report key: 17490568 · Received August 9, 2023

Report

Report Number
MW5122781
Event Type
Death
Date Received
August 9, 2023
Date of Event
July 21, 2023
Report Date
August 7, 2023
Manufacturer
MAQUET" GENTINGE GROUP / INTERVASCULAR, SAS
Product Code
MAL
Adverse Event
Yes
Product Problem
Yes
Report Source
Voluntary report
Reporter Occupation
RISK MANAGER
Health Professional
Yes

Narratives

Description of Event or Problem · 0

UNDERWENT HEART CAUTERIZATION FOR POSSIBLE INTERVENTION AND INSERTION OF IMPELLA AND ECMO DUE TO CARDIOGENIC SHOCK. DURING INSERTION OF BIFEMORAL GRAPH VIA CUTDOWN TO LEFT ARTERY, UNCONTROLLED BLEEDING. BLEEDING AT GRAPH SITE DESCRIBED AS "SPRAYING/ APPEARING AS A SPRINKLER". ESTIMATED BLOOD LOSS >4L. UNABLE TO CONTROL BLEEDING, PATIENT EXPIRED. THERAPEUTIC RANGE FOR HEPARIN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2014057 MAQUET - AXILLO-BIFEMORAL HEMOGARD KNITTED GRAFT, VASCULAR, SYNTHETIC/BIOLOGIC COMPOSITE MAL MAQUET" GENTINGE GROUP / INTERVASCULAR, SAS WATER PERM <5ML/CM2/MIN 22K06

Patients

Seq Age Sex Outcome Treatment
1 58 YR Female Death